Tower Research Capital LLC TRC lessened its stake in shares of Anthem Inc (NYSE:ANTM) by 79.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,407 shares of the company’s stock after selling 9,188 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Anthem were worth $659,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in ANTM. Iridian Asset Management LLC CT boosted its position in shares of Anthem by 129.1% during the 3rd quarter. Iridian Asset Management LLC CT now owns 1,569,169 shares of the company’s stock worth $430,031,000 after purchasing an additional 884,335 shares in the last quarter. Orbimed Advisors LLC bought a new position in shares of Anthem during the 2nd quarter worth about $126,584,000. Artisan Partners Limited Partnership boosted its position in shares of Anthem by 40.2% during the 2nd quarter. Artisan Partners Limited Partnership now owns 1,788,388 shares of the company’s stock worth $425,690,000 after purchasing an additional 512,962 shares in the last quarter. Natixis boosted its position in shares of Anthem by 76.1% during the 2nd quarter. Natixis now owns 767,992 shares of the company’s stock worth $182,805,000 after purchasing an additional 331,808 shares in the last quarter. Finally, Price Wealth Management Inc. bought a new position in shares of Anthem during the 2nd quarter worth about $327,000. 87.12% of the stock is currently owned by institutional investors.
NYSE:ANTM opened at $285.10 on Friday. The company has a quick ratio of 1.54, a current ratio of 1.53 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $75.76 billion, a price-to-earnings ratio of 23.68, a PEG ratio of 1.43 and a beta of 0.85. Anthem Inc has a 52 week low of $215.52 and a 52 week high of $300.57.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 21st. Shareholders of record on Wednesday, December 5th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Tuesday, December 4th. This represents a $3.00 annualized dividend and a yield of 1.05%. Anthem’s dividend payout ratio (DPR) is 24.92%.
In other news, EVP Thomas C. Zielinski sold 7,826 shares of the firm’s stock in a transaction that occurred on Wednesday, November 7th. The shares were sold at an average price of $289.71, for a total transaction of $2,267,270.46. Following the completion of the sale, the executive vice president now owns 29,466 shares in the company, valued at approximately $8,536,594.86. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Peter D. Haytaian sold 3,500 shares of the firm’s stock in a transaction that occurred on Friday, October 26th. The stock was sold at an average price of $267.59, for a total transaction of $936,565.00. Following the sale, the executive vice president now owns 48,206 shares of the company’s stock, valued at approximately $12,899,443.54. The disclosure for this sale can be found here. In the last quarter, insiders sold 20,826 shares of company stock valued at $5,815,620. Company insiders own 0.31% of the company’s stock.
ANTM has been the topic of a number of research analyst reports. Citigroup cut shares of Anthem from a “buy” rating to a “neutral” rating and set a $162.00 price objective on the stock. in a research report on Monday, September 10th. Jefferies Financial Group restated a “buy” rating and issued a $316.00 target price on shares of Anthem in a report on Friday, October 12th. Morgan Stanley upgraded shares of Anthem from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $273.00 to $368.00 in a report on Wednesday, September 5th. Credit Suisse Group upped their target price on shares of Anthem from $284.00 to $311.00 and gave the stock an “outperform” rating in a report on Tuesday, September 4th. Finally, BMO Capital Markets upped their target price on shares of Anthem from $300.00 to $310.00 and gave the stock a “buy” rating in a report on Thursday, November 1st. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $300.33.
COPYRIGHT VIOLATION NOTICE: This article was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.chaffeybreeze.com/2018/12/07/anthem-inc-antm-shares-sold-by-tower-research-capital-llc-trc.html.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Further Reading: Find a Trading Strategy That Works
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.